Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 1/1999

01-02-1999

The human NADH:ubiquinone oxidoreductase NDUFS5 (15kDa) subunit: cDNA cloning, chromosomal localization, tissue distribution and the absence of mutations in isolated complex I-deficient patients

Authors: J. Loeffen, R. Smeets, J. Smeitink, R. Triepels, R. Sengers, F. Trijbels, L. van den Heuvel

Published in: Journal of Inherited Metabolic Disease | Issue 1/1999

Login to get access
Metadata
Title
The human NADH:ubiquinone oxidoreductase NDUFS5 (15kDa) subunit: cDNA cloning, chromosomal localization, tissue distribution and the absence of mutations in isolated complex I-deficient patients
Authors
J. Loeffen
R. Smeets
J. Smeitink
R. Triepels
R. Sengers
F. Trijbels
L. van den Heuvel
Publication date
01-02-1999
Publisher
Kluwer Academic Publishers
Published in
Journal of Inherited Metabolic Disease / Issue 1/1999
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1023/A:1005434912463

Other articles of this Issue 1/1999

Journal of Inherited Metabolic Disease 1/1999 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine